Valuation: UCB

Market Cap 4.37TCr 5.05TCr 4.07TCr 3.75TCr 7.07TCr 4,79800Cr 7.15TCr 48TCr 19TCr 2,40100Cr 19TCr 19TCr 7,95000Cr P/E 2026 *
23.3x
P/E 2027 * 18.9x
Enterprise Value 4.39TCr 5.07TCr 4.09TCr 3.77TCr 7.11TCr 4,82300Cr 7.19TCr 48TCr 19TCr 2,41300Cr 19TCr 19TCr 7,99200Cr EV / Sales 2026 *
5.08x
EV / Sales 2027 * 4.31x
Free-Float
61.59%
Yield 2026 *
0.64%
Yield 2027 * 0.66%
1 day-0.31%
1 week+5.30%
Current month+2.51%
1 month-10.18%
3 months-3.18%
6 months-12.79%
Current year-4.23%
1 week 219.8
Extreme 219.8
232.9
1 month 214
Extreme 214
255.9
Current year 214
Extreme 214
289.5
1 year 181.15
Extreme 181.15
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 01/01/2015
Director of Finance/CFO 60 01/07/2020
Chief Tech/Sci/R&D Officer 59 01/05/2024
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Director/Board Member 67 01/01/2015
Director/Board Member 56 24/04/2014
Date Insider Type Main position Quantity % Market Cap.
15/01/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
15/01/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
15/01/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%+5.30%+25.00%+185.91% 5.05TCr
+1.04%+10.52%+34.86%+0.28% 7.67TCr
+1.02%+0.81%-7.73%+21.83% 4.85TCr
+1.30%+3.46%-50.91%-49.51% 4.41TCr
-0.87%-1.24%+55.49%-23.16% 3.05TCr
-0.66%-5.74%+54.13%+88.28% 2.43TCr
-1.29%+3.24%+104.79%-48.00% 2.25TCr
+0.72%+3.23%-7.24%+213.08% 2TCr
-0.10%-1.86%+66.61%+162.37% 1.6TCr
+0.34%-6.26%+64.32%+118.87% 1.61TCr
Average +0.75%-1.02%+33.93%+66.99% 3.49TCr
Weighted average by Cap. +0.62%+0.33%+24.73%+49.88%

Financials

2026 *2027 *
Net sales 865.04Cr 998.77Cr 806.37Cr 741.65Cr 1.4TCr 95TCr 1.42TCr 9.48TCr 3.72TCr 48TCr 3.75TCr 3.67TCr 1,57400Cr 969.96Cr 1.12TCr 904.18Cr 831.61Cr 1.57TCr 1,06500Cr 1.59TCr 11TCr 4.17TCr 53TCr 4.21TCr 4.11TCr 1,76500Cr
Net income 187.26Cr 216.21Cr 174.56Cr 160.55Cr 303.1Cr 21TCr 306.48Cr 2.05TCr 805.11Cr 10TCr 812.05Cr 794.15Cr 34TCr 234.19Cr 270.4Cr 218.31Cr 200.79Cr 379.06Cr 26TCr 383.29Cr 2.57TCr 1.01TCr 13TCr 1.02TCr 993.18Cr 43TCr
Net Debt 23Cr 26Cr 21Cr 20Cr 37Cr 2.51TCr 37Cr 249.97Cr 98Cr 1.25TCr 99Cr 97Cr 4.15TCr -194.01Cr -224Cr -180.85Cr -166.33Cr -314.01Cr -21TCr -317.52Cr -2.13TCr -834.11Cr -11TCr -841.3Cr -822.76Cr -35TCr
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
06/26/06 227.70 -0.65% 24,754
05/26/05 €229.20 +2.64% 2,64,506
04/26/04 €223.30 +0.86% 2,58,008
03/26/03 €221.40 -0.67% 3,05,551
31/26/31 €222.90 +2.72% 4,97,579
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
229.20EUR
Average target price
286.11EUR
Spread / Average Target
+24.83%

Quarterly revenue - Rate of surprise